배아줄기세포 유래의 인공 마이크로베시클을 이용한 역분화 유도만능줄기세포의 제조방법
    2.
    发明公开
    배아줄기세포 유래의 인공 마이크로베시클을 이용한 역분화 유도만능줄기세포의 제조방법 有权
    使用衍生自胚胎干细胞的微泡制备诱导性多能干细胞的方法

    公开(公告)号:KR1020120123624A

    公开(公告)日:2012-11-09

    申请号:KR1020110040202

    申请日:2011-04-28

    CPC classification number: C12N5/0696 A61K35/545 C12N2502/02 C12N2506/13

    Abstract: PURPOSE: A method for preparing induced pluripotent stem cells by treating a composition containing a microvesicle is provided to develop cell therapeutic agent. CONSTITUTION: A method for preparing induced pluripotent stem cells comprises a step of treating somatic cells with a composition containing embryonic stem cell-derived microvesicle. The embryonic stem cells are derived from human or non-human primates, mouse, rat, dog, cat, house, or horse. The microvesicle additionally contains components except for a cell membrane of embryonic stem cells. The components are cyclodextrin or polyethylene glycol. The composition additionally contains a component except for the microvesicle, such as BFA(brefeldin A), BIX(BiP inducer X), or VPA(valproic acid). A cell therapeutic agent contains the induced pluripotent stem cells. [Reference numerals] (AA) Embryonic stem cell; (BB) Microvesicle

    Abstract translation: 目的:提供一种通过处理含有微泡的组合物制备诱导性多能干细胞的方法,以开发细胞治疗剂。 构成:用于制备诱导性多能干细胞的方法包括用含有胚胎干细胞衍生的微泡的组合物处理体细胞的步骤。 胚胎干细胞衍生自人或非人灵长类动物,小鼠,大鼠,狗,猫,家或马。 微泡除了胚胎干细胞的细胞膜外,还含有成分。 组分是环糊精或聚乙二醇。 该组合物另外含有除了微泡之外的组分,例如BFA(布雷菲德菌素A),BIX(BiP诱导剂X)或VPA(丙戊酸))。 细胞治疗剂含有诱导的多能干细胞。 (附图标记)(AA)胚胎干细胞; (BB)微囊泡

Patent Agency Ranking